Patel Chem Specialities Ltd (544460) — FY26 Annual Report | 1 September 2026

Patel Chem Specialities Limited reported FY2025-26 revenue of ₹13,726.33 lakhs, up 30.6% YoY, with PAT at ₹1,255.22 lakhs (9.03% margin). EBITDA reached ₹1,889.24 lakhs (13.58% margin). Net worth surged to ₹9,949.95 lakhs and net debt/equity fell to 0.15x. The company completed its Talod plant expansion to 4,500 MT capacity and plans further capacity growth. It successfully listed on BSE SME in August 2025 after an oversubscribed IPO. Management highlighted strategic focus on scaling manufacturing, expanding global reach, and developing specialized excipients. No dividend was recommended. Key risks include raw material price volatility, regulatory changes, and competition. The Board emphasized sustainable growth through disciplined execution and quality standards.